[EN] DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES<br/>[FR] DÉRIVÉS DE DIHYDRO-CYCLOPENTA-ISOQUINOLINE
申请人:UCB BIOPHARMA SRL
公开号:WO2021130255A1
公开(公告)日:2021-07-01
The present invention relates to dihydro-cyclopenta-isoquinoline derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use in treating disorders caused by IgE (such as allergic responses, non-allergic mast cell responses or certain autoimmune responses), and in particular disorders caused by the interaction of IgE with the FcεRI receptor.
本发明涉及式(I)的二氢环戊基异喹啉衍生物,其制备方法,含有它们的药物组合物以及它们在治疗由IgE引起的疾病(如过敏反应、非过敏肥大细胞反应或某些自身免疫反应)中的用途,特别是由IgE与FcεRI受体相互作用引起的疾病。